Skip to content

Discontinued — last reported Q4 '23

Business Segments · D&A

Health & Biosciences — D&A

International Flavors & Fragrances Health & Biosciences — D&A remained flat by 0.0% to $93.5M in Q4 2023 compared to the prior quarter. Year-over-year, this metric grew by 3.0%, from $90.75M to $93.5M. Over 2 years (FY 2021 to FY 2023), Health & Biosciences — D&A shows relatively stable performance with a 2.9% CAGR.

Analysis

StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2019
Last reportedQ4 2023Feb 28, 2024
Rolls up toD&A

How to read this metric

A steady increase often correlates with high capital expenditure cycles, while a decrease may signal aging assets or reduced investment.

Detailed definition

This metric captures the non-cash allocation of the cost of tangible and intangible assets over their useful lives withi...

Peer comparison

Universal metric for capital-intensive industries to reconcile net income to cash flow.

Metric ID: iff_segment_health_biosciences_depreciation_and_amortization

Historical Data

3 years
 FY'21FY'22FY'23
Value$353M$363M$374M
YoY Change+2.8%+3.0%
Range$353M$374M
CAGR+2.9%
Avg YoY Growth+2.9%
Median YoY Growth+2.9%
Current Streak2+ years growth

Frequently Asked Questions

What is International Flavors & Fragrances's health & biosciences — d&a?
International Flavors & Fragrances (IFF) reported health & biosciences — d&a of $93.5M in Q4 2023.
How has International Flavors & Fragrances's health & biosciences — d&a changed year-over-year?
International Flavors & Fragrances's health & biosciences — d&a increased by 3.0% year-over-year, from $90.75M to $93.5M.
What is the long-term trend for International Flavors & Fragrances's health & biosciences — d&a?
Over 2 years (2021 to 2023), International Flavors & Fragrances's health & biosciences — d&a has grown at a 2.9% compound annual growth rate (CAGR), from $353M to $374M.
What does health & biosciences — d&a mean?
The non-cash expense representing the wear and tear or expiration of the segment's assets.